![Kevin Shaw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Shaw
Consigliere Generale presso
NEXTCURE, INC.
Profilo
Kevin G.
Shaw is currently General Counsel at NextCure, Inc. since 2023.
Formerly, Mr. Shaw was Vice President & Deputy General Counsel at Precigen, Inc. from 2012 to 2022.
Education includes undergraduate studies at the University of Pennsylvania and graduate studies at George Washington University Law School.
Posizioni attive di Kevin Shaw
| Società | Posizione | Inizio |
|---|---|---|
| NEXTCURE, INC. | Consigliere Generale | 01/05/2022 |
Precedenti posizioni note di Kevin Shaw
| Società | Posizione | Fine |
|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | 01/05/2022 |
Formazione di Kevin Shaw
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
36
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
George Washington University Law School
 George Washington University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
